Semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are injectable GLP-1 receptor agonist medications that are FDA approved for weight management and treating diabetes. These injections are typically administered once weekly, although the timing of injections may vary depending on the patient. Dosing will start at a lower dose. Arbor Medical and Aesthetics, a leading med spa in Ann Arbor, obtains its generic GLP-1 medications from a licensed registered pharmacy in the U.S. that is authorized to do compounding.
In addition to controlling diabetes and aiding in weight loss, these medications have also shown benefits for:
· Improving conditions aggravated by weight (such as osteoarthritis)
· Reducing the desire to consume alcohol
· Improving fatty liver
· Reducing cholesterol/lipids
· Lowering the risk of prediabetes advancing to diabetes
Possible side effects and risks include:
· Nausea, vomiting, diarrhea, heartburn
· Constipation
· Abdominal discomfort
· Injection site reactions – pain, bruising, bleeding, infection
· Fatigue
· Dizziness
Serious possible reactions include:
· Thyroid cancer risk
· Allergic reactions which could be severe
· Pancreatitis
· Kidney injury or aggravation of chronic kidney disease
· Ileus (bowel paralysis)
· Gallstones, cholecystitis
CONTRAINDICATIONS – DO NOT TAKE IF YOU HAVE:
· Current pregnancy or planning pregnancy
· Current breastfeeding
· History of medullary thyroid carcinoma
· History of multiple endocrine neoplasia syndrome type 2 (MEN2)
· Previous allergic reaction to tirzepatide or semaglutide
For those seeking weight management solutions and diabetes treatment in the area, visiting a reputable medspa in Ann Arbor, such as Arbor Medical and Aesthetics, can provide further guidance and support.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.